Home/Filings/4/0001127602-25-013014
4//SEC Filing

Romanelli Joseph 4

Accession 0001127602-25-013014

CIK 0000310158other

Filed

Apr 30, 8:00 PM ET

Accepted

May 1, 5:43 PM ET

Size

10.7 KB

Accession

0001127602-25-013014

Insider Transaction Report

Form 4
Period: 2025-04-29
Romanelli Joseph
President, Human Health Int?l
Transactions
  • Award

    Restricted Stock Unit

    2025-04-29+9,4449,444 total
    From: 2026-04-29Exp: 2028-04-29Common Stock (9,444 underlying)
  • Award

    Restricted Stock Unit

    2025-04-29+4,7224,722 total
    From: 2026-04-29Exp: 2028-04-29Common Stock (4,722 underlying)
  • Award

    Stock Option (Right to Buy)

    2025-04-29+21,49421,494 total
    Exercise: $84.71From: 2026-04-29Exp: 2035-04-28Common Stock (21,494 underlying)
Holdings
  • Common Stock

    21,798.545
Footnotes (4)
  • [F1]Holdings include shares acquired in dividend reinvestment transactions.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
  • [F3]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.
  • [F4]The option vests and becomes exercisable in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.

Issuer

Merck & Co., Inc.

CIK 0000310158

Entity typeother

Related Parties

1
  • filerCIK 0001938322

Filing Metadata

Form type
4
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 5:43 PM ET
Size
10.7 KB